Regulation of E2F: A family of transcription factors involved in proliferation control

Gene

Volumn 237, Issue 2, 1999, Pages 281-302

  Black, Adrian R ^a   Azizkhan Clifford, Jane ^a  

^a Roswell Cancer Institute   (United States)

Author keywords

Apoptosis; Cell cycle; Cell growth; Retinoblastoma; Transcription

Indexed keywords

RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F;

APOPTOSIS; CELL CYCLE; CELL GROWTH; CELL PROLIFERATION; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; TUMOR SUPPRESSOR GENE;

ANIMALS; CARRIER PROTEINS; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIVISION; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; HUMANS; TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTORS;

EID: 0032881249     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1119(99)00305-4     Document Type: Review

References (217)

1. Adams P.D., Sellers W.R., Sharma S.K., Wu A.D., Nalin C.M., Kaelin W.G. Jr. Identification of a cyclin-cdk2 recognition motif present in substrates and p21-like cyclin-dependent kinase inhibitors. Mol. Cell Biol. 16:1996;6623-6633.
2. Adnane J., Shao Z., Robbins P.D. The retinoblastoma susceptibility gene product represses transcription when directly bound to the promoter. J. Biol. Chem. 270:1995;8837-8843.
3. Akimoto M., Hangai M., Okazaki K., Kogishi J., Honda Y., Kaneda Y. Growth inhibition of cultured human Tenon's fibroblastic cells by targeting the E2F transcription factor. Exp. Eye Res. 67:1998;395-401.
4. Allen K.E., de la Luna S., Kerkhoven R.M., Bernards R., La Thangue N.B. Distinct mechanisms of nuclear accumulation regulate the functional consequence of E2F transcription factors. J. Cell Sci. 110:1997;2819-2831.
5. Altiok S., Xu M., Spiegelman B.M. PPARγ induces cell cycle withdrawal - inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A. Genes Dev. 11:1997;1987-1998.
6. Bagchi S., Weinmann R., Raychaudhuri P. The retinoblastoma protein copurifies with E2F-1, an E1A-regulated inhibitor of the transcription factor E2F. Cell. 65:1991;1063-1072.
7. Bandara L.R., La Thangue N.B. Adenovirus E1a prevents the retinoblastoma gene product from complexing with a cellular transcription factor. Nature. 351:1991;494-497.
8. Bandara L.R., Lam E.W., Sorensen T.S., Zamanian M., Girling R., La Thangue N.B. DP-1: a cell cycle-regulated and phosphorylated component of transcription factor DRTF1/E2F which is functionally important for recognition by pRb and the adenovirus E4 orf 6/7 protein. EMBO J. 13:1994;3104-3114.
9. Bandara L.R., Girling R., La Thangue N.B. Apoptosis induced in mammalian cells by small peptides that functionally antagonize the Rb-regulated E2F transcription factor. Nature Biotechnol. 15:1997;896-901.
10. Bargou R.C., Wagener C., Bommert K., Arnold W., Daniel P.T., Mapara M.Y., Grinstein E., Royer H.D., Dorken B. Blocking the transcription factor E2F/DP by dominant-negative mutants in a normal breast epithelial cell line efficiently inhibits apoptosis and induces tumor growth in SCID mice. J. Exp. Med. 183:1996;1205-1213.
11. Bennett L.M., Farnham P.J., Drinkwater N.R. Strain-dependent differences in DNA synthesis and gene expression in the regenerating livers of CB57BL/6J and C3H/HeJ mice. Mol. Carcinogen. 14:1995;46-52.
12. Bennett J.D., Farlie P.G., Watson R.J. E2F binding is required but not sufficient for repression of B-myb transcription in quiescent fibroblasts. Oncogene. 13:1996;1073-1082.
13. Bernards R. E2F - a nodal point in cell cycle regulation. Biochim. Biophys. Acta, Rev. Cancer. 1333:1997;M33-M40.
14. Birchenall-Roberts M.C., Yoo Y.D., Bertolette D.C., Lee K.H., Turley J.M., Bang O.S., Ruscetti F.W., Kim S.J. The p120-v-abl protein interacts with E2F-1 and regulates E2F-1 transcriptional activity. J. Biol. Chem. 272:1997;8905-8911.
15. Black A.R., Jensen D., Lin S.Y., Azizkhan J.C. Growth/cell cycle regulation of Sp1 phosphorylation. J. Biol. Chem. 274:1999;1207-1215.
16. Blake M.C., Azizkhan J.C. Transcription factor E2F is required for efficient expression of the hamster dihydrofolate reductase gene in vitro and in vivo. Mol. Cell Biol. 9:1989;4994-5002.
17. Blattner C., Sparks A., Lane D. Transcription factor E2F-1 is upregulated in response to DNA damage in a manner analogous to that of p53. Mol. Cell Biol. 19:1999;3704-3713.
18. Blau J., Xiao H., McCracken S., Ohare P., Greenblatt J., Bentley D. Three functional classes of transcriptional activation domains. Mol. Cell Biol. 16:1996;2044-2055.
19. Brehm A., Miska E.A., McCance D.J., Reid J.L., Bannister A.J., Kouzarides T. Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature. 391:1998;597-601.
20. Bremner R., Cohen B.L., Sopta M., Hamel P.A., Ingles C.J., Gallie B.L., Phillips R.A. Direct transcriptional repression by pRB and its reversal by specific cyclins. Mol. Cell Biol. 15:1995;3256-3265.
21. Callaghan D.A., Dong L., Callaghan S.M., Hou Y.X., Dagnino L., Slack R.S. Neural precursor cells differentiating in the absence of RB exhibit delayed terminal mitosis and deregulated E2F-1 and -3 activity. Dev. Biol. 207:1999;257-270.
22. Campanero M.R., Flemington E.K. Regulation of E2F through ubiquitin-proteasome-dependent degradation - stabilization by the pRB tumor suppressor protein. Proc. Natl. Acad. Sci. USA. 94:1997;2221-2226.
23. Cartwright P., Muller H., Wagener C., Holm K., Helin K. E2F-6: a novel member of the E2F family is an inhibitor of E2F-dependent transcription. Oncogene. 17:1998;611-623.
24. Chellappan S.P., Hiebert S., Mudryj M., Horowitz J.M., Nevins J.R. The E2F transcription factor is a cellular target for the RB protein. Cell. 65:1991;1053-1061.
25. Chen Y.-N., Sharma S.K., Ramsey T.M., Jiang L., Martin M.S., Baker K., Adams P.D., Bair K.W., Kaelin W.G. Selective killing of transformed cells by cyclin/cyclin-dependent kinase 2 antagonists. Proc. Natl. Acad. Sci. USA. 96:1999;. in press.
26. Chiarugi V., Magnelli L., Cinelli M., Basi G. Apoptosis and the cell cycle. Cell Mol. Biol. Res. 40:1994;603-612.
27. Chittenden T., Livingston D.M., Kaelin W.G. Jr. The T/E1A-binding domain of the retinoblastoma product can interact selectively with a sequence-specific DNA-binding protein. Cell. 65:1991;1073-1082.
28. Choubey D., Li S.J., Datta B., Gutterman J.U., Lengyel P. Inhibition of E2F-mediated transcription by p202. EMBO J. 15:1996;5668-5678.
29. Choubey D., Gutterman J.U. Inhibition of E2F-4/DP-1-stimulated transcription by p202. Oncogene. 15:1997;291-301.
30. Chow K.N., Dean D.C. Domains A and B in the Rb pocket interact to form a transcriptional repressor motif. Mol. Cell Biol. 16:1996;4862-4868.
31. Cress W.D., Nevins J.R. A role for a bent DNA structure in E2F-mediated transcription activation. Mol. Cell Biol. 16:1996;2119-2127.
32. Cui J.Q., Wang H., Reddy E.S., Rao V.N. Differential transcriptional activation by the N-terminal region of BRCA1 splice variants BRCA1a and BRCA1b. Oncol. Rep. 5:1998;585-589.
33. Dagnino L., Fry C.J., Bartley S.M., Farnham P., Gallie B.L., Phillips R.A. Expression patterns of the E2F family of transcription factors during mouse nervous system development. Mech. Dev. 66:1997;13-25.
34. Dagnino L., Fry C.J., Bartley S.M., Farnham P., Gallie B.L., Phillips R.A. Expression patterns of the E2F family of transcription factors during murine epithelial development. Cell Growth Differ. 8:1997;553-563.
35. DeGregori J., Leone G., Miron A., Jakoi L., Nevins J.R. Distinct roles for E2F proteins in cell growth control and apoptosis. Proc. Natl. Acad. Sci. USA. 94:1997;7245-7250.
36. de la Luna S., Burden M.J., Lee C.W., La Thangue N.B. Nuclear accumulation of the E2F heterodimer regulated by subunit composition and alternative splicing of a nuclear localization signal. J. Cell Sci. 109:1996;2443-2452.
37. de la Luna S., Allen K.E., Mason S.L., La Thangue N.B. Integration of a growth-suppressing BTB/POZ domain protein with the DP component of the E2F transcription factor. EMBO J. 18:1999;212-228.
38. KIP-overexpressing cells versus serum-starved or growing cells. Mol. Cell Biol. 18:1998;409-419.
39. De Luca P., Majello B., Lania L. Retinoblastoma protein tethered to promoter DNA represses TBP-mediated transcription. J. Cell Biochem. 70:1998;281-287.
40. Di Fiore B., Guarguaglini G., Palena A., Kerkhoven R.M., Bernards R., Lavia P. Two E2F sites control growth-regulated and cell cycle-regulated transcription of the Htf9-a/RanBP1 gene through functionally distinct mechanisms. J. Biol. Chem. 274:1999;10339-10348.
41. Dirks P.B., Rutka J.T., Hubbard S.L., Mondal S., Hamel P.A. The E2F-family proteins induce distinct cell cycle regulatory factors in p16-arrested, U343 astrocytoma cells. Oncogene. 17:1998;867-876.
42. Dobrowolski S.F., Stacey D.W., Harter M.L., Stine J.T., Hiebert S.W. An E2F dominant negative mutant blocks E1A induced cell cycle progression. Oncogene. 9:1994;2605-2612.
43. Dupont E., Sansal I., Evrard C., Rouget P. Developmental pattern of expression of NPDC-1 and its interaction with E2F-1 suggest a role in the control of proliferation and differentiation of neural cells. J. Neurosci. Res. 51:1998;257-267.
44. Dynlacht B.D., Brook A., Dembski M., Yenush L., Dyson N. DNA-binding and trans-activation properties of Drosophila E2F and DP proteins. Proc. Natl. Acad. Sci. USA. 91:1994;6359-6363.
45. Dynlacht B.D., Flores O., Lees J.A., Harlow E. Differential regulation of E2F transactivation by cyclin/cdk2 complexes. Genes Dev. 8:1994;1772-1786.
46. Dynlacht B.D. Regulation of transcription by proteins that control the cell cycle. Nature. 389:1997;149-152.
47. Dynlacht B.D., Moberg K., Lees J.A., Harlow E., Zhu L. Specific regulation of E2F family members by cyclin-dependent kinases. Mol. Cell Biol. 17:1997;3867-3875.
48. Emili A., Ingles C.J. Promoter-dependent photocross-linking of the acidic transcriptional activator E2F-1 to the TATA-binding protein. J. Biol. Chem. 270:1995;13674-13680.
49. Ewen M.E. Regulation of the cell cycle by the Rb tumor suppressor family. Results Probl. Cell Differ. 22:1998;149-179.
50. Fagan R., Flint K.J., Jones N. Phosphorylation of E2F-1 modulates its interaction with the retinoblastoma gene product and the adenoviral E4 19 kDa protein. Cell. 78:1994;799-811.
51. Fan J.G., Bertino J.R. Functional roles of E2F in cell cycle regulation. Oncogene. 14:1997;1191-1200.
52. Farnham P.J., Schimke R.T. Transcriptional regulation of mouse dihydrofolate reductase in the cell cycle. J. Biol. Chem. 260:1985;7675-7680.
53. Ferreira R., Magnaghi-Jaulin L., Robin P., Harel-Bellan A., Trouche D. The three members of the pocket proteins family share the ability to repress E2F activity through recruitment of a histone deacetylase. Proc. Natl. Acad. Sci. USA. 95:1998;10493-10498.
54. Field S.J., Tsai F.Y., Kuo F., Zubiaga A.M., Kaelin W.G., Livingston D.M., Orkin S.H., Greenberg M.E. E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell. 85:1996;549-561.
55. Flores A.M., Kassatly R.F., Cress W.D. E2F-3 accumulation is regulated by polypeptide stability. Oncogene. 16:1998;1289-1298.
56. kip1 and hypophosphorylation of the retinoblastoma protein in intestinal epithelial cells. J. Biol. Chem. 272:1997;9424-9435.
57. Fry C.J., Slansky J.E., Farnham P.J. Position-dependent transcriptional regulation of the murine dihydrofolate reductase promoter by the E2F transactivation domain. Mol. Cell Biol. 17:1997;1966-1976.
58. Fry C.J., Pearson A., Malinowski E., Bartley S.M., Greenblat J., Farnham P.J. Activation of the mouse dihydrofolate promoter by E2F-1: a requirement for CBP recruitment. J. Biol. Chem. 1999;. in press.
59. WAF1/CIP1 transcription by RB binding proteins. Oncogene. 17:1998;3463-3469.
60. Gaubatz S., Wood J.G., Livingston D.M. Unusual proliferation arrest and transcriptional control properties of a newly discovered E2F family member, E2F-6. Proc. Natl. Acad. Sci. USA. 95:1998;9190-9195.
61. Giaccia A.J., Kastan M.B. The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev. 12:1998;2973-2983.
62. Ginsberg D., Vairo G., Chittenden T., Xiao Z.X., Xu G., Wydner K.L., DeCaprio J.A., Lawrence J.B., Livingston D.M. E2F-4, a new member of the E2F transcription factor family, interacts with p107. Genes Dev. 8:1994;2665-2679.
63. Goldman P.S., Tran V.K., Goodman R.H. The multifunctional role of the co-activator CBP in transcriptional regulation. Recent Progr. Horm. Res. 52:1997;103-119.
64. Grana X., Garriga J., Mayol X. Role of the retinoblastoma protein family, pRB, p107 and p130 in the negative control of cell growth. Oncogene. 17:1998;3365-3383.
65. Grossman S.R., Perez M., Kung A.L., Joseph M., Mansur C., Xiao Z.X., Kumar S., Howley P.M., Livingston D.M. p300/MDM2 complexes participate in MDM2-mediated p53 degradation. Mol. Cell. 2:1998;405-415.
66. Guy C.T., Zhou W., Kaufman S., Robinson M.O. E2F-1 blocks terminal differentiation and causes proliferation in transgenic megakaryocytes. Mol. Cell Biol. 16:1996;685-693.
67. Haas-Kogan D.A., Kogan S.C., Levi D., Dazin P., T'Ang A., Fung Y.K., Israel M.A. Inhibition of apoptosis by the retinoblastoma gene product. EMBO J. 14:1995;461-472.
68. Hagemeier C., Cook A., Kouzarides T. The retinoblastoma protein binds E2F residues required for activation in vivo and TBP binding in vitro. Nucleic Acids Res. 21:1993;4998-5004.
69. Hateboer G., Kerkhoven R.M., Shvarts A., Bernards R., Beijersbergen R.L. Degradation of E2F by the ubiquitin-proteasome pathway, regulation by retinoblastoma family proteins and adenovirus transforming proteins. Genes Dev. 10:1996;2960-2970.
70. Hengstschlager M., Knofler M., Mullner E.W., Ogris E., Wintersberger E., Wawra E. Different regulation of thymidine kinase during the cell cycle of normal versus DNA tumor virus-transformed cells. J. Biol. Chem. 269:1994;13836-13842.
71. Hengstschlager M., Holzl G., Hengstschlager-Ottnad E. Different regulation of c-Myc and E2F-1-induced apoptosis during the ongoing cell cycle. Oncogene. 18:1999;843-848.
72. Hiebert S.W., Lipp M., Nevins J.R. E1A-dependent trans-activation of the human MYC promoter is mediated by the E2F factor. Proc. Natl. Acad. Sci. USA. 86:1989;3594-3598.
73. Hiyama H., Iavarone A., Reeves S.A. Regulation of the cdk inhibitor p21 gene during cell cycle progression is under the control of the transcription factor E2F. Oncogene. 16:1998;1513-1523.
74. Hofferer M., Wirbelauer C., Humar B., Krek W. Increased levels of E2F-1-dependent DNA binding activity after UV- or gamma-irradiation. Nucleic Acids Res. 27:1999;491-495.
75. 1 exit. Genes Dev. 10:1996;851-861.
76. Hofmann F., Martelli F., Livingston D.M., Wang Z. The retinoblastoma gene product protects E2F-1 from degradation by the ubiquitin-proteasome pathway. Genes Dev. 10:1996;2949-2959.
77. Hsieh J.K., Fredersdorf S., Kouzarides T., Martin K., Lu X. E2F1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction. Genes Dev. 11:1997;1840-1852.
78. Hsieh J.K., Chan F.S., O'Connor D.J., Mittnacht S., Zhong S., Lu X. RB regulates the stability and the apoptotic function of p53 via MDM2. Mol. Cell. 3:1999;181-193.
79. Huang Y.Y., Ishiko T., Nakada S., Utsugisawa T., Kato T., Yuan Z.M. Role for E2F in DNA damage-induced entry of cells into S-phase. Cancer Res. 57:1997;3640-3643.
80. Huber H.E., Edwards G., Goodhart P.J., Patrick D.R., Huang P.S., Ivey-Hoyle M., Barnett S.F., Oliff A., Heimbrook D.C. Transcription factor E2F binds DNA as a heterodimer. Proc. Natl. Acad. Sci. USA. 90:1993;3525-3529.
81. Huber H.E., Goodhart P.J., Huang P.S. Retinoblastoma protein reverses DNA bending by transcription factor E2F. J. Biol. Chem. 269:1994;6999-7005.
82. Hurford R.K., Cobrinik D., Lee M.H., Dyson N. pRb and p107/p130 are required for the regulated expression of different sets of E2F responsive genes. Genes Dev. 11:1997;1447-1463.
83. Ikeda M.A., Jakoi L., Nevins J.R. A unique role for the Rb protein in controlling E2F accumulation during cell growth and differentiation. Proc. Natl. Acad. Sci. USA. 93:1996;3215-3220.
84. Jensen D.E., Black A.R., Swick A.G., Azizkhan J.C. Distinct roles for Sp1 and E2F sites in the growth/cell cycle regulation of the DHFR promoter. J. Cell Biochem. 67:1997;24-31.
85. Jooss K., Lam E.W., Bybee A., Girling R., Muller R., La Thangue N.B. Proto-oncogenic properties of the DP family of proteins. Oncogene. 10:1995;1529-1536.
86. Kaelin W.G., Krek W., Sellers W.R., DeCaprio J.A., Ajchanbaum F., Fuchs C.S., Chittenden T., Li Y., Farnham P.J., Blanar M.A., Livingston D.M., Flemington E.K. Expression cloning of a cDNA encoding a retinoblastoma binding protein with E2F-like properties. Cell. 70:1992;351-364.
87. Karlseder J., Rotheneder H., Wintersberger E. Interaction of Sp1 with the growth- and cell cycle-regulated transcription factor E2F. Mol. Cell Biol. 16:1996;1659-1667.
88. Kim S.J., Onwuta U.S., Lee Y.I., Li R., Botchan M.R., Robbins P.D. The retinoblastoma gene product regulates Sp1-mediated transcription. Mol. Cell Biol. 12:1992;2455-2463.
89. King K.L., Cidlowski J.A. Cell cycle regulation and apoptosis. Ann. Rev. Physiol. 60:1998;601-617.
90. Kitagawa M., Higashi H., Suzuki-Takahashi I., Segawa K., Hanks S.K., Taya Y., Nishimura S., Okuyama A. Phosphorylation of E2F-1 by cyclin A-cdk2. Oncogene. 10:1995;229-236.
91. Kiuchi N., Nakajima K., Ichiba M., Fukada T., Narimatsu M., Mizuno K., Hibi M., Hirano T. STAT3 is required for the gp130-mediated full activation of the c-myc gene. J. Exp. Med. 189:1999;63-73.
92. Kovesdi I., Reichel R., Nevins J.R. Identification of a cellular transcription factor involved in E1A trans-activation. Cell. 45:1986;219-228.
93. Kowalik T.F., DeGregori J., Schwarz J.K., Nevins J.R. E2F1 overexpression in quiescent fibroblasts leads to induction of cellular DNA synthesis and apoptosis. J. Virol. 69:1995;2491-2500.
94. Kowalik T.F., DeGregori J., Leone G., Jakoi L., Nevins J.R. E2F1-specific induction of apoptosis and p53 accumulation, which is blocked by Mdm2. Cell Growth Differ. 9:1998;113-118.
95. Krek W., Ewen M.E., Shirodkar S., Arany Z., Kaelin W.G. Jr., Livingston D.M. Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase. Cell. 78:1994;161-172.
96. Krek W., Xu G., Livingston D.M. Cyclin A-kinase regulation of E2F-1 DNA binding function underlies suppression of an S-phase checkpoint. Cell. 83:1995;1149-1158.
97. LaBaer J., Garrett M.D., Stevenson L.F., Slingerland J.M., Sandhu C., Chou H.S., Fattaey A., Harlow E. New functional activities for the p21 family of CDK inhibitors. Genes Dev. 11:1997;847-862.
98. Lam E.W., Watson R.J. An E2F-binding site mediates cell-cycle regulated repression of mouse B-myb transcription. EMBO J. 12:1993;2705-2713.
99. Lania L., Majello B., Napolitano G. Transcriptional control by cell-cycle regulators: a review. J. Cell Physiol. 179:1999;134-141.
100. Larminie C.G.D., Cairns C.A., Mital R., Martin K., Kouzarides T.S.P.J., White R.J. Mechanistic analysis of RNA polymerase III regulation by the retinoblastoma protein. EMBO J. 16:1997;2061-2071.
101. LeCouter J.E., Kablar B., Whyte P.F., Ying C., Rudnicki M.A. Strain-dependent embryonic lethality in mice lacking the retinoblastoma-related p130 gene. Development. 125:1998;4669-4679.
102. Lee C.W., Sorensen T.S., Shikama N., Lathangue N.B. Functional interplay between p53 and E2F through co-activator p300. Oncogene. 16:1998;2695-2710.
103. Leone G., DeGregori J., Yan Z., Jakoi L., Ishida S., Williams R.S., Nevins J.R. E2F3 activity is regulated during the cell cycle and is required for the induction of S-phase. Genes Dev. 12:1998;2120-2130.
104. waf1 leads to increased inhibition of E2F-1 phosphorylation and sensitivity to anticancer drugs in retinoblastoma-negative human sarcoma cells. Cancer Res. 57:1997;2193-2199.
105. Lin S.-Y., Black A.R., Kostic A., Pajovic S., Hoover C.N., Azizkhan J.C. Cell cycle-regulated association of E2F1 and Sp1 is related to their functional interaction. Mol. Cell Biol. 16:1996;1668-1675.
106. Lindeman G.J., Gaubatz S., Livingston D.M., Ginsberg D. The subcellular localization of E2F-4 is cell-cycle dependent. Proc. Natl. Acad. Sci. USA. 94:1997;5095-5100.
107. Lindeman G.J., Dagnino L., Gaubatz S., Xu Y., Bronson R.T., Warren H.B., Livingston D.M. A specific, nonproliferative role for E2F-5 in choroid plexus function revealed by gene targeting. Genes Dev. 12:1998;1092-1098.
108. Liu N., Lucibello F.C., Zwicker J., Engeland K., Muller R. Cell cycle-regulated repression of B-myb transcription: cooperation of an E2F site with a contiguous corepressor element. Nucleic Acids Res. 24:1996;2905-2910.
109. Liu N., Lucibello F.C., Engeland K., Muller R. A new model of cell cycle-regulated transcription: repression of the cyclin A promoter by CDF-1 and anti-repression by E2F. Oncogene. 16:1998;2957-2963.
110. Loiseau L., Pasteau S., Brun G. Molecular cloning and expression pattern of the DP members of the chicken E2F transcription factor. Gene Expr. 6:1997;259-273.
111. 1 checkpoint. Mol. Cell Biol. 16:1996;6917-6925.
112. Luo R.X., Postigo A.A., Dean D.C. Rb interacts with histone deacetylase to repress transcription. Cell. 92:1998;463-473.
113. Macleod K.F., Hu Y.W., Jacks T. Loss of Rb activates both p53-dependent and independent cell death pathways in the developing mouse nervous system. EMBO J. 15:1996;6178-6188.
114. Maeshima Y., Kashihara N., Yasuda T., Sugiyama H., Sekikawa T., Okamoto K., Kanao K., Watanabe Y., Kanwar Y.S., Makino H. Inhibition of mesangial cell proliferation by E2F decoy oligodeoxynucleotide in vitro and in vivo. J. Clin. Invest. 101:1998;2589-2597.
115. Magae J., Wu C.L., Illenye S., Harlow E., Heintz N.H. Nuclear localization of DP and E2F transcription factors by heterodimeric partners and retinoblastoma protein family members. J. Cell Sci. 109:1996;1717-1726.
116. Magae J., Illenye S., Chang Y.C., Mitsui Y., Heintz N.H. Association with E2F-1 governs intracellular trafficking and polyubiquitination of DP-1. Oncogene. 18:1999;593-605.
117. Magnaghi-Jaulin L., Groisman R., Naguibneva I., Robin P., Lorain S., Le Villain J.P., Troalen F., Trouche D., Harel-Bellan A. Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature. 391:1998;601-605.
118. Mai B., Lipp M. Identification of a protein from Saccharomyces cerevisiae with E2F-like DNA-binding and transactivating properties. FEBS Lett. 321:1993;153-158.
119. Majello B., De Luca P., Suske G., Lania L. Differential transcriptional regulation of c-myc promoter through the same DNA binding sites targeted by Sp1-like proteins. Oncogene. 10:1995;1841-1848.
120. Martelli F., Livingston D.M. Regulation of endogenous E2F1 stability by the retinoblastoma family proteins. Proc. Natl. Acad. Sci. USA. 96:1999;2858-2863.
121. Martin K., Trouche D., Hagemeier C., Sorensen T.S., Lathangue N.B., Kouzarides T. Stimulation of E2F1/DP1 transcriptional activity by mdm2 oncoprotein. Nature. 375:1995;691-694.
122. Meng R.D., Phillips P., El-Deiry W.S. p53-independent increase in E2F-1 expression enhances the cytotoxic effects of etoposide and of adriamycin. Int. J. Oncol. 14:1999;5-14.
123. Moberg K., Starz M.A., Lees J.A. E2F-4 switches from p130 to p107 and pRB in response to cell cycle re-entry. Mol. Cell Biol. 16:1996;1436-1449.
124. Morishita R., Gibbons G.H., Horiuchi M., Ellison K.E., Nakama M., Zhang L., Kaneda Y., Ogihara T., Dzau V.J. A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo. Proc. Natl. Acad. Sci. USA. 92:1995;5855-5859.
125. Morkel M., Wenkel J., Bannister A.J., Kouzarides T., Hagemeier C. An E2F-like repressor of transcription. Nature. 390:1997;567-568. letter.
126. Mudryj M., Devoto S.H., Hiebert S.W., Hunter T., Pines J., Nevins J.R. Cell cycle regulation of the E2F transcription factor involves an interaction with cyclin A. Cell. 65:1991;1243-1253.
127. Muller H., Moroni M.C., Vigo E., Petersen B.O., Bartek J., Helin K. Induction of S-phase entry by E2F transcription factors depends on their nuclear localization. Mol. Cell Biol. 17:1997;5508-5520.
128. Neuman E., Flemington E.K., Sellers W.R., Kaelin W.G. Jr. Transcription of the E2F-1 gene is rendered cell cycle dependent by E2F DNA binding within its own promoter. Mol. Cell Biol. 14:1994;6607-6615.
129. Nevins J.R. Cell cycle targets of the DNA tumor viruses. Curr. Opin. Genet. Dev. 4:1994;130-134.
130. 2 phases of the cell cycle. J. Cell Biol. 135:1996;441-456.
131. O'Connor D.J., Lam E.W., Griffin S., Zhong S., Leighton L.C., Burbidge S.A., Lu X. Physical and functional interactions between p53 and cell cycle co-operating transcription factors, E2F1 and DP1. EMBO J. 14:1995;6184-6192.
132. 1/S-regulated E2F-containing protein complexes bind to the mouse thymidine kinase gene promoter. Mol. Cell Biol. 14:1994;1603-1612.
133. Ohtani K., DeGregori J., Leone G., Herendeen D.R., Kelly T.J., Nevins J.R. Expression of the HsORC1 gene, a human ORC1 homolog, is regulated by cell proliferation via the E2F transcription factor. Mol. Cell Biol. 16:1996;6977-6984.
134. Ohtani-Fujita N., Fujita T., Takahashi R., Robbins P.H., Dryja T.P., Sakai T. A silencer element in the retinoblastoma tumor-suppressor gene. Oncogene. 9:1994;1703-1711.
135. Ormondroyd E., de la Luna S., La Thangue N.B. A new member of the DP family, DP-3, with distinct protein products suggests a regulatory role for alternative splicing in the cell cycle transcription factor DRTF1/E2F. Oncogene. 11:1995;1437-1446.
136. Pajovic S., Wong E.L., Black A.R., Azizkhan J.C. Identification of a viral kinase that phosphorylates specific E2Fs and pocket proteins. Mol. Cell Biol. 17:1997;6459-6464.
137. Pasteau S., Loiseau L., Arnaud L., Trembleau A., Brun G. Isolation and characterization of a chicken homolog of the E2F-1 transcription factor. Oncogene. 11:1995;1475-1486.
138. Pearson A., Greenblatt J. Modular organization of the E2F1 activation domain and its interaction with general transcription factors TBP and TFIIH. Oncogene. 15:1997;2643-2658.
139. Peeper D.S., Keblusek P., Helin K., Toebes M., van der Eb A.J., Zantema A. Phosphorylation of a specific cdk site in E2F-1 affects its electrophoretic mobility and promotes pRB-binding in vitro. Oncogene. 10:1995;39-48.
140. Peter M. The regulation of cyclin-dependent kinase inhibitors (CKIs). Progr. Cell Cycle Res. 3:1997;99-108.
141. Phillips A.C., Bates S., Ryan K.M., Helin K., Vousden K.H. Induction of DNA synthesis and apoptosis are separable functions of E2F-1. Genes Dev. 11:1997;1853-1863.
142. Pierce A.M., Schneider-Broussard R., Philhower J.L., Johnson D.G. Differential activities of E2F family members: unique functions in regulating transcription. Mol. Carcinogen. 22:1998;190-198.
143. Pruschy M., Wirbelauer C., Glanzmann C., Bodis S., Krek W. E2F-1 has properties of a radiosensitizer and its regulation by cyclin A kinase is required for cell survival of fibrosarcoma cells lacking p53. Cell Growth Differ. 10:1999;141-146. in process citation.
144. Qin X.Q., Livingston D.M., Kaelin W.G. Jr., Adams P.D. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl. Acad. Sci. USA. 91:1994;10918-10922.
145. Raschella G., Tanno B., Bonetto F., Negroni A., Claudio P.P., Baldi A., Amendola R., Calabretta B., Giordano A., Paggi M.G. The Rb-related gene Rb2/p130 in neuroblastoma differentiation and in b-myb promoter down-regulation. Cell Death Differ. 5:1998;401-407.
146. Rogers K.T., Higgins P.D.R., Milla M.M., Phillips R.S., Horowitz J.M. DP-2, a heterodimeric partner of E2F - identification and characterization of DP-2 proteins expressed in vivo. Proc. Natl. Acad. Sci. USA. 93:1996;7594-7599.
147. Ross J.F., Liu X., Dynlacht B.D. Mechanism of transcriptional repression of E2F by the retinoblastoma tumor suppressor protein. Mol. Cell. 3:1999;195-205.
148. 1-S progression from an associated transcriptional program. Genes Dev. 11:1997;1999-2011.
149. Rubin E., Tamrakar S., Ludlow J.W. Protein phosphatase type 1, the product of the retinoblastoma susceptibility gene, and cell cycle control. Front Biosci. 3:1998;D1209-D1919.
150. Sardet C., Vidal M., Cobrinik D., Geng Y., Onufryk C., Chen A., Weinberg R.A. E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle. Proc. Natl. Acad. Sci. USA. 92:1995;2403-2407.
151. Sardet C., LeCam L., Fabbrizio E., Vidal M. E2Fs and the retinoblastoma family. Yaniv M., Ghysdael J. Cell Cycle Regulators and Chromosomal Translocation. Oncogenes as Transcriptional Regulators. Vol. 2:1997;1-62 Birkhauser Verlag, Basel, Switzerland.
152. Sawado T., Yamaguchi M., Nishimoto Y., Ohno K., Sakaguchi K., Matsukage A. dE2F2, a novel E2F-family transcription factor in Drosophila melanogaster. Biochem. Biophys. Res. Commun. 251:1998;409-415.
153. Saxon M.L., Zhao X., Black J.D. Activation of protein kinase C isozymes is associated with post-mitotic events in intestinal epithelial cells in situ. J. Cell Biol. 126:1994;747-763.
154. Sears R., Ohtani K., Nevins J.R. Identification of positively and negatively acting elements regulating expression of the E2F2 gene in response to cell growth signals. Mol. Cell Biol. 17:1997;5227-5235.
155. Sellers W.R., Rodgers J.W., Kaelin W.G. Jr. A potent transrepression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites. Proc. Natl. Acad. Sci. USA. 92:1995;11544-11548.
156. Sellers W.R., Novitch B.G., Miyake S., Heith A., Otterson G.A., Kaye F.J., Lassar A.B., Kaelin W.G. Jr. Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation and suppress tumor cell growth. Genes Dev. 12:1998;95-106.
157. Shan B., Lee W.H. Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol. Cell Biol. 14:1994;8166-8173.
158. Shan B., Durfee T., Lee W.H. Disruption of RB/E2F-1 interaction by single point mutations in E2F-1 enhances S-phase entry and apoptosis. Proc. Natl. Acad. Sci. USA. 93:1996;679-684.
159. Shan B., Farmer A.A., Lee W.H. The molecular basis of E2F-1/DP-1-induced S-phase entry and apoptosis. Cell Growth Differ. 7:1996;689-697.
160. Sherr C.J. Cancer cell cycles. Science. 274:1996;1672-1677.
161. Singh P., Wong S.H., Hong W. Overexpression of E2F-1 in rat embryo fibroblasts leads to neoplastic transformation. EMBO J. 13:1994;3329-3338.
162. Sladek T.L. E2F transcription factor action, regulation and possible role in human cancer. Cell Prolif. 30:1997;97-105.
163. Slansky J.E., Li Y., Kaelin W.G., Farnham P.J. A protein synthesis-dependent increase in E2F1 mRNA correlates with growth regulation of the dihydrofolate reductase promoter. Mol. Cell Biol. 13:1993;1610-1618.
164. 1 cell state. Mol. Cell Biol. 16:1996;6965-6976.
165. Smith E.J., Leone G., Nevins J.R. Distinct mechanisms control the accumulation of the Rb-related p107 and p130 proteins during cell growth. Cell Growth Differ. 9:1998;297-303.
166. Snowden A.W., Perkins N.D. Cell cycle regulation of the transcriptional coactivators p300 and CREB binding protein. Biochem. Pharmacol. 55:1998;1947-1954.
167. Soferlevi Y., Resnitzky D. Apoptosis induced by ectopic expression of cyclin D1 but not cyclin E. Oncogene. 13:1996;2431-2437.
168. Sorensen T.S., Girling R., Lee C.W., Gannon J., Bandara L.R., Lathangue N.B. Functional interaction between DP-1 and p53. Mol. Cell Biol. 16:1996;5888-5895.
169. Souza R.F., Yin J., Smolinski K.N., Zou T.T., Wang S., Shi Y.Q., Rhyu M.G., Cottrell J., Abraham J.M., Biden K., Simms L., Leggett B., Bova G.S., Frank T., Powell S.M., Sugimura H., Young J., Harpaz N., Shimizu K., Matsubara N., Meltzer S.J. Frequent mutation of the E2F-4 cell cycle gene in primary human gastrointestinal tumors. Cancer Res. 57:1997;2350-2353.
170. Starostik P., Chow K.N., Dean D.C. Transcriptional repression and growth suppression by the p107 pocket protein. Mol. Cell Biol. 16:1996;3606-3614.
171. Stiegler P., De Luca A., Bagella L., Giordano A. The COOH-terminal region of pRb2/p130 binds to histone deacetylase 1 (HDAC1), enhancing transcriptional repression of the E2F-dependent cyclin A promoter. Cancer Res. 58:1998;5049-5052.
172. Stiegler P., Kasten M., Giordano A. The RB family of cell cycle regulatory factors. J. Cell Biochem. Suppl. 31:1998;30-36.
173. ARF, participates in a regulatory feedback loop with p53 and MDM2. EMBO J. 17:1998;5001-5014.
174. Strom D.K., Cleveland J.L., Chellappan S., Nip J., Hiebert S.W. E2F-1 and E2F-3 are functionally distinct in their ability to promote myeloid cell cycle progression and block granulocyte differentiation. Cell Growth Differ. 9:1998;59-69.
175. Struhl K. Histone acetylation and transcriptional regulatory mechanisms. Genes Dev. 12:1998;599-606.
176. Suzuki M., Okuyama S., Okamoto S., Shirasuna K., Nakajima T., Hachiya T., Nojima H., Sekiya S., Oda K. A novel E2F binding protein with Myc-type HLH motif stimulates E2F-dependent transcription by forming a heterodimer. Oncogene. 17:1998;853-865.
177. Tao Y., Kassatly R.F., Cress W.D., Horowitz J.M. Subunit composition determines E2F DNA-binding site specificity. Mol. Cell Biol. 17:1997;6994-7007.
178. Tevosian S.G., Paulson K.E., Bronson R., Yee A.S. Expression of the E2F-1/DP-1 transcription factor in murine development. Cell Growth Differ. 7:1996;43-52.
179. Tevosian S.G., Shih H.H., Mendelson K.G., Sheppard K.A., Paulson K.E., Yee A.S. HBP1 - a HMG box transcriptional repressor that is targeted by the retinoblastoma family. Genes Dev. 11:1997;383-396.
180. Tomita N., Horiuchi M., Tomita S., Gibbons G.H., Kim J.Y., Baran D., Dzau V.J. An oligonucleotide decoy for transcription factor E2F inhibits mesangial cell proliferation in vitro. Am. J. Physiol. 275:1998;F278-F284.
181. Trimarchi J.M., Fairchild B., Verona R., Moberg K., Andon N., Lees J.A. E2F-6, a member of the E2F family that can behave as a transcriptional repressor. Proc. Natl. Acad. Sci. USA. 95:1998;2850-2855.
182. Trouche D., Cook A., Kouzarides T. The CBP co-activator stimulates E2F1/DP1 activity. Nucleic Acids Res. 24:1996;4139-4145.
183. Tsai K.Y., Hu Y., Macleod K.F., Crowley D., Yamasaki L., Jacks T. Mutation of E2F-1 suppresses apoptosis and inappropriate S-phase entry and extends survival of Rb-deficient mouse embryos. Mol. Cell. 2:1998;293-304.
184. Turley J.M., Ruscetti F.W., Kim S.J., Fu T., Gou F.V., Birchenall-Roberts M.C. Vitamin E succinate inhibits proliferation of BT-20 human breast cancer cells: increased binding of cyclin A negatively regulates E2F transactivation activity. Cancer Res. 57:1997;2668-2675.
185. Udvadia A.J., Templeton D.J., Horowitz J.M. Functional interactions between the retinoblastoma (Rb) protein and Sp-family members: superactivation by Rb requires amino acids necessary for growth suppression. Proc. Natl. Acad. Sci. USA. 92:1995;3953-3957.
186. Vaishnav Y.N., Vaishnav M.Y., Pant V. The molecular and functional characterization of E2F-5 transcription factor. Biochem. Biophys. Res. Commun. 242:1998;586-592.
187. 0 to S-phase transition in human promary B-lymphocyctes. J. Biol. Chem. 274:1999;12009-12016.
188. Van Ginkel P.R., Hsiao K.M., Schjerven H., Farnham P.J. E2F-mediated growth regulation requires transcription factor cooperation. J. Biol. Chem. 272:1996;18367-18374.
189. van Wijnen A.J., Cooper C., Odgren P., Aziz F., De Luca A., Shakoori R.A., Giordano A., Quesenberry P.J., Lian J.B., Stein G.S., Stein J.L. Cell cycle-dependent modifications in activities of pRb-related tumor suppressors and proliferation-specific CDP/cut homeodomain factors in murine hematopoietic progenitor cells. J. Cell Biochem. 66:1997;512-523.
190. Verona R., Moberg K., Estes S., Starz M., Vernon J.P., Lees J.A. E2F activity is regulated by cell cycle-dependent changes in subcellular localization. Mol. Cell Biol. 17:1997;7268-7282.
191. Vidal M., Braun P., Chen E., Boeke J.D., Harlow E. Genetic characterization of a mammalian protein-protein interaction domain by using a yeast reverse two-hybrid system. Proc. Natl. Acad. Sci. USA. 93:1996;10321-10326.
192. Voit R., Schafer K., Grummt I. Mechanism of repression of RNA polymerase I transcription by the retinoblastoma protein. Mol. Cell Biol. 17:1997;4230-4237.
193. 0 exit of resting mouse embryo fibroblasts. Proc. Natl. Acad. Sci. USA. 95:1998;15583-15586.
194. Wang S., Nath N., Minden A., Chellappan S. Regulation of Rb and E2F by signal transduction cascades: divergent effects of JNK1 and p38 kinases. EMBO J. 18:1999;1559-1570.
195. Weintraub S.J., Prater C.A., Dean D.C. Retinoblastoma protein switches the E2F site from positive to negative element. Nature. 358:1992;259-261.
196. Weintraub S.J., Chow K.N., Luo R.X., Zhang S.H., He S., Dean D.C. Mechanism of active transcriptional repression by the retinoblastoma protein. Nature. 375:1995;812-815.
197. Welch P.J., Wang J.Y. A C-terminal protein-binding domain in the retinoblastoma protein regulates nuclear c-abl tyrosine kinase in the cell cycle. Cell. 75:1993;779-790.
198. Wells J.M., Illenye S., Magae J., Wu C.L., Heintz N.H. Accumulation of E2F-4/DP-1 DNA binding complexes correlates with induction of DHFR gene expression during the G(1) to S-phase transition. J. Biol. Chem. 272:1997;4483-4492.
199. Williams C.D., Linch D.C., Sorensen T.S., Lathangue N.B., Thomas N.S.B. The predominant E2F complex in human primary haemopoietic cells and in AML blasts contains E2F-4, DP-1 and p130. Br. J. Haematol. 96:1997;688-696.
200. Woo M.S.A., Sanchez I., Dynlacht B.D. p130 and p107 use a conserved domain to inhibit cellular cyclin-dependent kinase activity. Mol. Cell Biol. 17:1997;3566-3579.
201. Wu X., Levine A.J. p53 and E2F-1 cooperate to mediate apoptosis. Proc. Natl. Acad. Sci. USA. 91:1994;3602-3606.
202. 1. Mol. Cell Biol. 16:1996;3698-3706.
203. Xiao Z.X., Chen J., Levine A.J., Modjtahedi N., Xing J., Sellers W.R., Livingston D.M. Interaction between the retinoblastoma protein and the oncoprotein MDM2. Nature. 375:1995;694-698.
204. Xu M., Sheppard K.A., Peng C.Y., Yee A.S., Piwnica-Worms H. Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation. Mol. Cell Biol. 14:1994;8420-8431.
205. Xu G.F., Livingston D.M., Krek W. Multiple members of the E2F transcription factor family are the products of oncogenes. Proc. Natl. Acad. Sci. USA. 92:1995;1357-1361.
206. Yamasaki L., Jacks T., Bronson R., Goillot E., Harlow E., Dyson N.J. Tumor induction and tissue atrophy in mice lacking E2F-1. Cell. 85:1996;537-548.
207. Yamasaki L. Growth regulation by the E2F and DP transcription factor families. Results Probl. Cell Differ. 22:1998;199-227.
208. Yang X.H., Sladek T.L. Novel phosphorylated forms of E2F-1 transcription factor bind to the retinoblastoma protein in cells overexpressing an E2F-1 cDNA. Biochem. Biophys. Res. Comm. 232:1997;336-339.
209. Yee A.S., Shih H.H., Tevosian S.G. New perspectives on retinoblastoma family functions in differentiation. Front Biosci. 3:1998;D532-D547.
210. Zacksenhaus E., Jiang Z., Chung D., Marth J.D., Phillips R.A., Gallie B.L. pRb controls proliferation, differentiation, and death of skeletal muscle cells and other lineages during embryogenesis. Genes Dev. 10:1996;3051-3064.
211. Zhang Y., Chellappan S.P. Cloning and characterization of human DP2, a novel dimerization partner of E2F. Oncogene. 10:1995;2085-2093.
212. Zhang S., Varma A., Williamson P.R. The yeast cryptococcus neoformans uses 'mammalian' enhancer sites in the regulation of the virulence gene, CNLAC1. Gene. 227:1999;231-240.
213. ink4a, TGFβ, and contact inhibition. Cell. 97:1999;53-61.
214. Zheng N., Fraenkel E., Pabo C.O., Pavletich N.P. Structural basis of DNA recognition by the heterodimeric cell cycle transcription factor E2F-DP. Genes Dev. 13:1999;666-674.
215. Zhu L.G., Zhu L.Y., Xie E.Z., Chang L.S. Differential roles of two tandem E2F sites in repression of the human p107 promoter by retinoblastoma and p107 proteins. Mol. Cell Biol. 15:1995;3552-3562.
216. Zwicker J., Lucibello F.C., Wolfraim L.A., Gross C., Truss M., Engeland K., Muller R. Cell cycle regulation of the cyclin A, cdc25C and cdc2 genes is based on a common mechanism of transcriptional repression. EMBO J. 14:1995;4514-4522.
217. Zwicker J., Liu N., Engeland K., Lucibello F.C., Muller R. Cell cycle regulation of E2F site occupation in vivo. Science. 271:1996;1595-1597.